INDV FY 2020 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$647M-17.6% YoY

Gross Profit

$550M85.0% margin

Operating Income

-$156M-24.1% margin

Net Income

-$148M-22.9% margin

EPS (Diluted)

$-1.08

Cash Flow

Operating Cash Flow

-$193M

Free Cash Flow

-$197M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.4B

Stockholders' Equity

$82M

Cash & Equivalents

$858M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$647M	$785M	-17.6%
Gross Profit	$550M	$645M	-14.7%
Operating Income	-$156M	$178M	-187.6%
Net Income	-$148M	$134M	-210.4%